Endogenous Modulation and Central Sensitization in New Daily Persistent Headache ( NDPH ) in Children

NCT03447782 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

New Daily Persistent Headache (NDPH)

Interventions

DRUG: Naltrexone HCl (Bulk) Powder

Sponsor

Boston Children's Hospital